Alumis ALMS
NASDAQ ALMS
$11.16 -0.19 (-1.72%)
As of: Sep 4, 2026 · 2:37 PM EDT

Alumis (ALMS) Cash from Investing Activities (2023 - 2025)

Alumis (ALMS) posted quarterly Cash from Investing Activities of $95.0 million for Q4 2025, up 206.99% year-over-year from $31.0 million in Q4 2024, and up 295.29% quarter-over-quarter from $24.0 million in Q3 2025.

Analysis

Alumis (ALMS) Cash from Investing Activities (2023 - 2025) Analysis & Trends

Alumis (ALMS) has reported Cash from Investing Activities for 3 consecutive years, with $95.0 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Cash from Investing Activities rose 206.99% year-over-year to $95.0 million; the TTM figure through Dec 2025 stood at $287.9 million (up 352.99% YoY), while the FY2025 annual figure was $287.9 million, up 352.99% from the prior year.
  • Cash from Investing Activities advanced to $95.0 million in Q4 2025 per ALMS's latest filing, from $24.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $129.4 million in Q2 2025 and bottomed at -$93.2 million in Q3 2024.
  • Historically, Cash from Investing Activities has averaged $17.8 million across 3 years, with a median of $15.8 million in 2023.
  • On a YoY basis, Cash from Investing Activities climbed as much as 846.86% in 2024 and fell as far as 1330.06% in 2024.
  • Alumis' Cash from Investing Activities stood at -$4.1 million in 2023, then surged by 846.86% to $31.0 million in 2024, then jumped by 206.99% to $95.0 million in 2025.
  • Business Quant data shows ALMS's Cash from Investing Activities at $95.0 million in Q4 2025, $24.0 million in Q3 2025, and $129.4 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - -1.66 Bn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn - -229.72 Mn
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn 24.51 Mn
10 Alumis 1.43 Bn 924.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 95.01 Mn
Sep 30, 2025 24.04 Mn
Jun 30, 2025 129.40 Mn
Mar 31, 2025 39.43 Mn
Dec 31, 2024 30.95 Mn
Sep 30, 2024 -93.19 Mn
Jun 30, 2024 -32.74 Mn
Mar 31, 2024 -18.81 Mn
Dec 31, 2023 -4.14 Mn
Sep 30, 2023 7.58 Mn